Corrigendum: Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma.

Y-box binding protein-1 biomarker lung cancer mesothelioma targeted therapy

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
Historique:
received: 22 10 2019
accepted: 06 11 2019
entrez: 7 12 2019
pubmed: 7 12 2019
medline: 7 12 2019
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fcell.2019.00221.].

Identifiants

pubmed: 31807495
doi: 10.3389/fcell.2019.00293
pmc: PMC6883175
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

293

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2019 Johnson, Schelch, Mehta, Burgess and Reid.

Références

EMBO Rep. 2009 Jul;10(7):783-9
pubmed: 19483673
J Cell Biol. 2015 Mar 30;208(7):913-29
pubmed: 25800057
Atherosclerosis. 2018 Nov;278:156-165
pubmed: 30278358
Genes (Basel). 2018 Oct 22;9(10):null
pubmed: 30360431

Auteurs

Thomas G Johnson (TG)

Asbestos Diseases Research Institute, Sydney, NSW, Australia.
Cell Division Laboratory, The ANZAC Research Institute, Sydney, NSW, Australia.
School of Medicine, The University of Sydney, Sydney, NSW, Australia.
Sydney Catalyst Translational Cancer Research Centre, The University of Sydney, Sydney, NSW, Australia.

Karin Schelch (K)

Institute of Cancer Research, Medical University of Vienna, Vienna, Austria.

Sunali Mehta (S)

Department of Pathology, University of Otago, Dunedin, New Zealand.
Maurice Wilkins Centre, University of Otago, Dunedin, New Zealand.

Andrew Burgess (A)

Cell Division Laboratory, The ANZAC Research Institute, Sydney, NSW, Australia.
School of Medicine, The University of Sydney, Sydney, NSW, Australia.

Glen Reid (G)

Department of Pathology, University of Otago, Dunedin, New Zealand.
Maurice Wilkins Centre, University of Otago, Dunedin, New Zealand.

Classifications MeSH